| Title |
Topical capsaicin (low concentration) for chronic neuropathic pain in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2012
|
| DOI | 10.1002/14651858.cd010111 |
| Pubmed ID | |
| Authors |
Sheena Derry, R Andrew Moore |
| Abstract |
Topical creams with capsaicin are used to treat pain from a wide range of chronic conditions including neuropathic pain. Following application to the skin capsaicin causes enhanced sensitivity to noxious stimuli, followed by a period with reduced sensitivity and, after repeated applications, persistent desensitisation. There is uncertainty about the efficacy and tolerability of capsaicin for treating painful chronic neuropathies. This is an update of an earlier review of topical capsaicin for chronic neuropathic pain in adults that looked at all doses and formulations of capsaicin. The original review has now been split: here we consider only formulations using a low concentration of capsaicin (< 1%) applied several times daily over several weeks, while another review will consider a single application of capsaicin at a high concentration. |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 3 | 12% |
| United States | 2 | 8% |
| Spain | 2 | 8% |
| Mexico | 2 | 8% |
| United Kingdom | 2 | 8% |
| Colombia | 2 | 8% |
| New Zealand | 1 | 4% |
| Australia | 1 | 4% |
| Ireland | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 10 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 81% |
| Practitioners (doctors, other healthcare professionals) | 4 | 15% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 165 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Unknown | 164 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 16% |
| Student > Bachelor | 23 | 14% |
| Researcher | 16 | 10% |
| Other | 12 | 7% |
| Student > Ph. D. Student | 11 | 7% |
| Other | 28 | 17% |
| Unknown | 49 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 60 | 36% |
| Nursing and Health Professions | 15 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Psychology | 6 | 4% |
| Agricultural and Biological Sciences | 4 | 2% |
| Other | 21 | 13% |
| Unknown | 50 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2022.
All research outputs
#1,744,419
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#3,757
of 13,156 outputs
Outputs of similar age
#10,922
of 187,712 outputs
Outputs of similar age from Cochrane database of systematic reviews
#66
of 231 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,712 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.